Literature DB >> 1396746

Fungal infections in cancer patients: an international autopsy survey.

G Bodey1, B Bueltmann, W Duguid, D Gibbs, H Hanak, M Hotchi, G Mall, P Martino, F Meunier, S Milliken.   

Abstract

In an attempt to estimate the frequency of fungal infections among cancer patients, a survey of autopsy examinations was conducted in multiple institutions in Europe, Japan and Canada. Fungal infections were identified most often in leukemic patients and transplant recipients (25% each). Fifty-eight percent of fungal infections were caused by Candida spp. and 30% by Aspergillus spp. There was considerable variability in the frequency of fungal infections in different countries. Nevertheless, this study clearly demonstrates that fungal infections represent a common complication in cancer patients, especially in patients with leukemia.

Entities:  

Mesh:

Year:  1992        PMID: 1396746     DOI: 10.1007/bf01967060

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  55 in total

1.  Proceedings: Causes of death in cancer patients.

Authors:  J Inagaki; V Rodriguez; G P Bodey
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

2.  A statistical survey of deep mycoses in Japan, with particular reference to autopsy cases of cryptococcosis.

Authors:  M Kanda; M Moriyama; M Ikeda; S Kojima; M Tokunaga
Journal:  Acta Pathol Jpn       Date:  1974-09

3.  Disseminated candidiasis in surgical patients.

Authors:  H E Bernhardt; J C Orlando; J R Benfield; F M Hirose; R Y Foos
Journal:  Surg Gynecol Obstet       Date:  1972-05

4.  The compromised host and infection. II. Deep fungal infection.

Authors:  P D Hart; E Russell; J S Remington
Journal:  J Infect Dis       Date:  1969-08       Impact factor: 5.226

Review 5.  Candida: an increasingly important pathogen in the nursery.

Authors:  K M Butler; C J Baker
Journal:  Pediatr Clin North Am       Date:  1988-06       Impact factor: 3.278

Review 6.  The emergence of fungi as major hospital pathogens.

Authors:  G P Bodey
Journal:  J Hosp Infect       Date:  1988-02       Impact factor: 3.926

7.  Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients.

Authors:  P Martino; M Venditti; A Micozzi; G Morace; L Polonelli; M P Mantovani; M C Petti; V L Burgio; C Santini; P Serra
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

Review 8.  Aspergillosis.

Authors:  G P Bodey; S Vartivarian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

9.  Systemic candidiasis in cancer patients.

Authors:  A W Maksymiuk; S Thongprasert; R Hopfer; M Luna; V Fainstein; G P Bodey
Journal:  Am J Med       Date:  1984-10-30       Impact factor: 4.965

10.  Candidiasis in the burned patient.

Authors:  M J Spebar; B A Pruitt
Journal:  J Trauma       Date:  1981-03
View more
  95 in total

1.  In vitro activities of pentamidine, pyrimethamine, trimethoprim, and sulfonamides against Aspergillus species.

Authors:  Javier Afeltra; Jacques F G M Meis; Roxana G Vitale; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 2.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

3.  Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients.

Authors:  Z Erjavec; G M Woolthuis; H G de Vries-Hospers; W J Sluiter; S M Daenen; B de Pauw; M R Halie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

4.  Emerging Issues in Nosocomial Fungal Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

5.  Production and characterization of recombinant Aspergillus fumigatus Cu,Zn superoxide dismutase and its recognition by immune human sera.

Authors:  M D Holdom; B Lechenne; R J Hay; A J Hamilton; M Monod
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.

Authors:  Russell E Lewis; Randall A Prince; Jingduan Chi; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

7.  Environmental monitoring for Aspergillus fumigatus in association with an immunosuppressed rabbit model of pulmonary aspergillosis.

Authors:  Kimberly A Such; Vidmantas Petraitis; Ruta Petraitiene; Gittel E Strauss; Patriss-Wais Moradi; Thomas J Walsh
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

8.  Effect of antimicrobial and antineoplastic drugs on the uptake of fluconazole by human neutrophils and tissue culture cells.

Authors:  I García; A Pascual; C Conejo; J Salvador; E J Perea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

9.  Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients.

Authors:  R Ansorg; E Heintschel von Heinegg; P M Rath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

10.  Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Dieter Buchheidt; Corinna Baust; Heyko Skladny; Wolfgang Seifarth; Udo Zeilfelder; Christine Leib-Mösch; Handan Mörz; Rüdiger Hehlmann
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.